Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors

Clinical Cancer Research

Volumn 9, Issue 2, 2003, Pages 779-785

  Schindl, Monika ^a   Schoppmann, Sebastian F ^a   Ströbel, Thomas ^b   Heinzl, Harald ^a   Leisser, Christina ^a   Horvat, Reinhard ^a   Birner, Peter ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; INHIBITOR OF DIFFERENTIATION 1; PROTEIN P21; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CYSTADENOMA; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HELIX-LOOP-HELIX MOTIFS; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MICROCIRCULATION; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 0037316988     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Norton, J. D., Deed, R. W., Craggs, G., and Sablitzky, F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol., 8: 58-65, 1998.
2. Lin, C. Q., Singh, J., Murata, K., Itahana. Y., Parrinello, S., Liang, S. H., Gillet, C. E., Campisi, J., and Desprez, P. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res., 60: 1332-1340. 2000.
3. Arnold, J. M., Mok, S. C., Purdle, D., and Chenevix-Trench, G. Decreased expression of the ID3 gene at 1p36.1 in ovarian adenocarcinomas. Br. J. Cancer, 84: 352-359, 2001.
4. Israel, M. A., Hernandez, M. C., Florio, M., Andres-Barquin, P. J., Mantani, A., Carter, J. H., and Julin, C. M. Id gene expression as a key mediator of tumor cell biology. Cancer Res., 59: 1726s-1730s, 1999.
5. Lasorella, A., Iavarone, A., and Israel, M. A. Id2 specially alters regulation of the cell cycle by tumor suppressor proteins. Mol. Cell. Biol., 16: 2570-2578, 1996.
6. Norton, J. D., and Atherton, G. T. Coupling of cell growth control and apoptosis functions of ID proteins. Mol. Cell. Biol., 18: 2371-2381, 1998.
7. Lyden, D., Young, A. Z., Zagzag, D., Yan, W., Gerald, W., O'Relly, R., Bader, B. L., Hynes, R. O., Zhuang, Y., Manova, K., and Benezra, R. Id1 and Id3 are required for neurogensis, angiogenesis and vascularization of tumour xenografts. Nature (Lond.), 401: 670-677, 1999.
8. Schindl, M., Oberhuber, G., Obermair, A., Schoppmann, S. F., Karner, B., and Birner, P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res., 61: 5703-5706, 2001.
9. Kebebew, E., Treseler, P. A., Duh, Q. Y., and Clark, O. H. The helix-loop-helix transcription factor. Id-1, is overexpressed in medullary throid cancer. Surgery (St. Louis), 128: 952-957, 2000.
10. Langlands, K., Down, G. A., and Kealey, T. Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma. Cancer Res., 60: 5929-5933, 2000.
11. Maruyama, H., Kleef, J., Wildi, S., Friess, H., Büchler, M. W., Israel, M. A., and Korc, M. Id-1 and Id-2 are overexpressed in pancreatic cancer and in dyplastic lesions in chronic pancreatitis. Am. J. Pathol., 155: 815-822, 1999.
12. Berek, J. S. Epithelial ovarian cancer. In: J. S. Berek and N. F. Hacker (eds.), Practical Gynecologic Oncology, pp. 327-375, Baltimore: Williams & Wilkins, 1994.
13. Boring, C. C., Squires, T. S., Tong, T., and Montgomery, S. Cancer statistics, 1994. CA Cancer J. Clin., 44: 7-26, 1994.
14. Lasorella, A., Uo, T., and Iavarone, A. Id proteins at the cross-road of development and cancer. Oncogene, 20: 8326-8333, 2001.
15. Prabhu, S., Ignatova, A., Park, S. T., and Sun, X. H. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol. Cell. Biol., 17: 5888-5896, 1997.
16. Birner, P., Gatterbauer, B., Drobna, D., and Bernheimer, H. Molecular mimicry in infectious encephalitis and neuritis: binding of antibodies against infectious agents on western blots of human nervous tissue. J. Infect., 41: 32-38, 2000.
17. Schmider, A., Gee, C., Friedmann, W., Lukas, J. J., Press, M. F., Lichtenegger, W., and Reles, A. p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma. Gynecol. Oncol., 77: 237-242, 2000.
18. Birner, P., Schindl, M., Obermair, A., Breitenecker, G., and Oberhuber, G. Expression of hypoxia-inducible factor (HIF) 1α in epithelial ovarian tumors: Its impact on prognosis and on response to chemotherapy. Clin. Cancer Res., 7: 1661-1668, 2001.
19. Schindl, M., Birner, P., Obermair, A., Kiesel, L., and Wenzl, R. Increased microvessel density in adenomyosis uteri. Fertil. Steril., 75: 131-135, 2001.
20. Dorai, H., and Sampath. T. K. Bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture. J. Bone Joint Surg. Am., 83-A(Suppl. 1): S70-S80, 2001.
21. Birner, P., Schindl, M., Obermair, A., Plank, C., Breitenecker, G., and Oberhuber, G. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early stage invasive cervical cancer. Cancer Res., 60: 4693-4696, 2000.
22. Weidner, N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res. Treat., 36: 169-180, 1995.
23. Werness, B. A., Freedman, A. N., Piver, M. S., Romero-Gutierrez, M., and Petrow, E. Prognostic significance of p53 and p21 (waf1/cip1) immunoreactivity in epithelial cancers of the ovary. Gynecol. Oncol., 75: 413-418, 1999.
24. Obermair, A., Wasicky, R., Kaider, A., Preyer, O., Lösch, A., Leodolter, S., and Kölbl, H. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer. Cancer Lett., 138: 175-182, 1999.
25. Gasparini, G., Bonoldi, E., Viale, G., Verderio, P., Boracchi, P., Panizzoni, G. A., Radaelli, U., Di Bacco, A., Guglielmi, R. B., and Bevilacqua, P. Prognostic and predictive value of tumor angiogenesis in ovarian carcinomas. Int. J. Cancer, 69: 205-211, 1996.
26. Heimburg, S., Oehler, M. K., Papadopoulos, T., Caffier, H., Kristen, P., and Dietl, J. Prognostic relevance of the endothelial marker CD 34 in ovarian cancer. Anticancer Res., 19: 2527-2529, 1999.
27. Kaplan, E. L., and Meier, P. Non parametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1985.
28. Le Jossic, K., Ilyin, G. P., Loyer, P., Glaise, D., Cariou, S., and Guguen-Guillouzo, C. Expression of helix-loop-helix factor Id-1 is dependent on the hepatocyte proliferation and differentiation status in rat liver and in primary culture. Cancer Res., 54: 6065-6068, 1994.
29. Ouyang, X. S., Wang, X., Lee, D. T., Tsao, S. W., and Wong, Y. C. Up-regulation of TRPM-2. MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat. Carcinogenesis (Lond.), 22: 965-973, 2001.
30. Alani, R. M., Young, A. Z., and Shifflet, C. B. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc. Natl. Acad. Sci. USA, 98: 7812-7816, 2001.
31. Ohtani, N., Zebedee, Z., Huot, T. J., Stinson, J. A., Sugimoto, M., Ohashi, Y., Sharrocks, A. D., Peter, G., and Hara, E. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature (Lond.), 409: 1067-1070, 2001.